Company intelligence / Profile preview
Loxagen
Palo Alto, CA, United Statesloxagen.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Loxagen is a biotechnology company focused on developing neuroprotective therapies for stroke and other neurodegenerative diseases. The company's lead candidate, BPN-27332, is a highly selective small molecule inhibitor of the 12/15-lipoxygenase (ALOX15) enzyme, which is a key driver of neuronal death and blood-brain barrier breakdown following brain injury. Loxagen's research, supported by over $10 million in funding and the NIH Blueprint Neurotherapeutics Program, aims to address the significant unmet need in subarachnoid hemorrhage (SAH) and ischemic stroke. The company is currently evaluating its lead compound in the Stroke Preclinical Assessment Network (SPAN) to prepare for future clinical trials.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
National Institutes of Health (NIH)Massachusetts General Hospital (MGH)
Beyond the preview
Go deeper on Loxagen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Loxagen.